Recruiting
Phase 2

Genetic Testing in Guiding Treatment for Patients With Brain Metastases

Sponsor:

Alliance for Clinical Trials in Oncology

Code:

NCT03994796

Conditions

CDK Gene Mutation

Metastatic Malignant Neoplasm in the Brain

Metastatic Malignant Solid Neoplasm

NTRK Family Gene Mutation

PI3K Gene Mutation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Abemaciclib

PI3K Inhibitor paxalisib

Entrectinib

Adagrasib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information